Cover Image
市場調查報告書

Intellect Neurosciences, Inc.:產品平台分析

Intellect Neurosciences, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 259396
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Intellect Neurosciences, Inc.:產品平台分析 Intellect Neurosciences, Inc. - Product Pipeline Review - 2015
出版日期: 2015年10月30日 內容資訊: 英文 30 Pages
簡介

Intellect Neurosciences, Inc.ha是開發老年癡呆症以及其他危及生命的神經疾病治療藥和預防藥的生物醫藥品企業。

本報告提供Intellect Neurosciences, Inc.的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Intellect Neurosciences, Inc.的基本資料

Intellect Neurosciences, Inc.概要

  • 主要資訊
  • 企業資料

Intellect Neurosciences, Inc.:R&D概要

  • 主要的治療範圍

Intellect Neurosciences, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Intellect Neurosciences, Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Intellect Neurosciences, Inc.:藥物簡介

  • INN-01
  • INN01-OX2
  • RV-01
  • RV-02
  • RV-03
  • TauC3單株抗體
  • T-01OX2
  • TOC-1

Intellect Neurosciences, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Intellect Neurosciences, Inc.:最近的開發平台趨勢

Intellect Neurosciences, Inc.:暫停中的計劃

Intellect Neurosciences, Inc.:企業發表

Intellect Neurosciences, Inc.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07710CDB

Summary

Global Markets Direct's, 'Intellect Neurosciences, Inc. - Product Pipeline Review - 2015', provides an overview of the Intellect Neurosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Intellect Neurosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Intellect Neurosciences, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Intellect Neurosciences, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Intellect Neurosciences, Inc.'s pipeline products

Reasons to buy

  • Evaluate Intellect Neurosciences, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Intellect Neurosciences, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Intellect Neurosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Intellect Neurosciences, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Intellect Neurosciences, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Intellect Neurosciences, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Intellect Neurosciences, Inc. Snapshot
    • Intellect Neurosciences, Inc. Overview
    • Key Information
    • Key Facts
  • Intellect Neurosciences, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Intellect Neurosciences, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Intellect Neurosciences, Inc. - Pipeline Products Glance
    • Intellect Neurosciences, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Intellect Neurosciences, Inc. - Drug Profiles
    • INN-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • INN01-OX2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RV-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RV-02
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RV-03
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TauC-3
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TOC-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Intellect Neurosciences, Inc. - Pipeline Analysis
    • Intellect Neurosciences, Inc. - Pipeline Products by Target
    • Intellect Neurosciences, Inc. - Pipeline Products by Route of Administration
    • Intellect Neurosciences, Inc. - Pipeline Products by Molecule Type
    • Intellect Neurosciences, Inc. - Pipeline Products by Mechanism of Action
  • Intellect Neurosciences, Inc. - Recent Pipeline Updates
  • Intellect Neurosciences, Inc. - Dormant Projects
  • Intellect Neurosciences, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Intellect Neurosciences, Inc., Key Information
  • Intellect Neurosciences, Inc., Key Facts
  • Intellect Neurosciences, Inc. - Pipeline by Indication, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Stage of Development, 2015
  • Intellect Neurosciences, Inc. - Monotherapy Products in Pipeline, 2015
  • Intellect Neurosciences, Inc. - Out-Licensed Products in Pipeline, 2015
  • Intellect Neurosciences, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Intellect Neurosciences, Inc. - Preclinical, 2015
  • Intellect Neurosciences, Inc. - Discovery, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Target, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Route of Administration, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Molecule Type, 2015
  • Intellect Neurosciences, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Intellect Neurosciences, Inc. - Recent Pipeline Updates, 2015
  • Intellect Neurosciences, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Intellect Neurosciences, Inc. - Pipeline by Top 10 Indication, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Stage of Development, 2015
  • Intellect Neurosciences, Inc. - Monotherapy Products in Pipeline, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Top 10 Target, 2015
  • Intellect Neurosciences, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Intellect Neurosciences, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top